Cognito Therapeutics
@cognitotx
Followers
1K
Following
167
Media
42
Statuses
319
Cognito Therapeutics is developing a novel device-based approach to treating Alzheimer’s disease. Learn about our pivotal study: https://t.co/yTzyuGOAaD
Cambridge, MA
Joined November 2016
Join us at #AAIC25 (July 27–31), where we will be presenting five new research abstracts highlighting the neuroprotective potential of our investigational non-invasive therapy, Spectris™, for Alzheimer's. Read our press release: https://t.co/CI6w2X4net
2
1
5
Daily at-home #gamma stimulation treatment with the #Spectris device was shown to preserve brain structure and slow cognitive decline in people with #Alzheimer disease in data presented at #AACI2025. https://t.co/tAnkkcXnSe
@cognitotx @alzassociation @AANmember
practicalneurology.com
Daily at-home sensory gamma stimulation treatment with the Spectris device (Cognito Therapeutics, Cambridge, MA) may help preserve brain structure and slo…
0
1
4
Daily at-home #gamma stimulation treatment with the #Spectris device was shown to preserve brain structure and slow cognitive decline in people with #Alzheimer disease in data presented at #AACI2025. https://t.co/FgIPbdsNNR
@cognitotx @alzassociation @AANmember
practicalneurology.com
Daily at-home sensory gamma stimulation treatment with the Spectris device (Cognito Therapeutics, Cambridge, MA) may help preserve brain structure and slo…
0
1
1
🧠 This week at #AAIC2025, we’re presenting five new data sets from our OVERTURE study that reinforce the neuroprotective potential of Spectris™, our investigational non-invasive therapy, for Alzheimer’s disease. @alzassociation
https://t.co/bsxQ5XdVVj
businesswire.com
Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease at AAIC 2025
1
2
4
0
1
3
Analysis indicates @cognitotx neuromodulation therapy delays #Alzheimers disease progression: https://t.co/gr0phAiFlD
0
1
1
How many times do you go to a #healthcare conference… learn something new AND get a full-on belly laugh? Highly recommend attending a panel with @cognito therapeutics CEO, Christian Howell! #Alzheimers #Neuromodulation #MedTech #BIO2025
0
1
2
Cognito Therapeutics' neuromod helps Alzheimer's patients hold onto memories longer $CGTX @cognitotx #neuromodulation #neurology #Alzheimers #dementia
ml.firstwordhealthtech.com
Cognito Therapeutics on Wednesday reported promising results from a post hoc analysis of the OVERTURE trial, which assessed the effectiveness of its Spectris AD neuromodulation therapy in delaying ...
0
1
2
Another inspiring voice joining the #AIforGood Global Summit 2025! Join us as Christian F. Howell, CEO of @cognitotx, shares his vision on the future of non-invasive #BCI. Join us for free or go VIP! 🌐 https://t.co/Q016UDbILV 📅 8–11 July 2025 📍 Palexpo, Geneva, and online
0
2
2
The first day of #InterfaceNeuroGT is wrapping up with a presentation from the generous sponsors of our meeting: @protocollabs, @Medtronic, @BlackRock, and @cognitotx. These companies are bringing cutting edge technologies, therapies, and research to the fold.
0
1
2
.@fwhealthtech covers our recent #ADPD25 results for #Spectris in #Alzheimers. 🧠🧠 Read the article: https://t.co/94AUGaZjgy
ml.firstwordhealthtech.com
Cognito Therapeutics said new data from the OVERTURE feasibility trial demonstrate that Spectris, its non-invasive neuromodul...
0
0
0
What role does Gamma stimulation therapy have in the treatment of AD🧐? How does a physics-based approach differ from what’s on market? Stay tuned for a conversation with @cognitotx’s Ralph Kern, MD, who discussed the company’s device, Spectris 🧠⚡️🔬and its effect on corpus
0
2
3
Excited to announce our new data from the OVERTURE study at @adpdnet for #Spectris in #Alzheimers disease. 🧠🧠 Read our press release: https://t.co/8ecrOMriNn
businesswire.com
Cognito Therapeutics Announces Spectris™ Data Demonstrating Brain Structural Maintenance and Mechanism of Action in Alzheimer’s Disease at AD/PD™ 2025
1
0
1
Our CEO Christian Howell will be presenting on March 10 at 10.30 am ET at the #InvestivalShowcase 2025. @LSXLeaders More info: https://t.co/5CtynFvfue
0
1
1
🧠 Emerging treatments are coming online for #Alzheimers, developed with the goal of clearing harmful plaques and improving #brain function without the use of #drugs or invasive procedures. 🔗 Here's more:
0
1
4
We’re excited to sponsor the 6th Bioelectronic Medicine Summit on March 4-5 in New York. Our CMO Dr. Ralph Kern will be giving a keynote on March 5 at 8.45 am ET. 🧠🧠 More info: https://t.co/q3MHF8JtRI
0
0
2
We’re excited to welcome 4 key leadership appointments to accelerate the company’s growth, clinical advancement, and commercialization. Welcome to the Cognito team! 🙌🙌 https://t.co/OkNnwGrww4
1
0
3
We announced the publication of a study in Alzheimer's & Dementia: Translational Research & Clinical Interventions that highlights myelin and synaptic biomarker changes in #Alzheimer’s patients treated with our non-invasive medical device, Spectris™. 🧠 https://t.co/3a9AjoinLF
businesswire.com
Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced the publication of a study in Al...
0
0
1
Available today: Ideagen's Catalyze Impact Weekly Podcast—spotlighting leaders driving change across industries! Ep. 6 features Christian Howell , Chief Executive Officer, Cognito Therapeutics. Tune in at https://t.co/1bZ7sXMv3h!
#CatalyzeImpact
0
1
1